FedSearch - Federated network search engine

cafepharma · @cafepharma

11 followers · 103 posts · Server toot.community

BMS signs ADC development deal with Munich-based biotech worth more than $1B —BeiGene's gastric cancer drug succeeds in late-stage trial— FDA green lights Roche's Polivy in first-line DLBCL-- See more on our front page news http://bit.ly/w28kSd #bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

#bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Last updated 1 year ago

Original post

ashish(@tp53) · @acgt01

43 followers · 974 posts · Server genomic.social

Nature - Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome - Nature Medicine

RT @SatyenGohil@twitter.com

Great work investigating #CLL and transformation to #Richters from @ErinMParry@twitter.com, CathyWu and @getz_lab@twitter.com @gaddyg@twitter.com. Real insights into disease biology of this hard to treat lymphoma and why it's harder to treat compared to #DLBCL @NatureMedicine@twitter.com
https://www.nature.com/articles/s41591-022-02113-6

🐦🔗: https://twitter.com/SatyenGohil/status/1612594860485234688

#CLL #richters #dlbcl

Last updated 2 years ago

Original post

Karine Crozat · @KarineCrozat

41 followers · 5 posts · Server fediscience.org

First evidence that Tumor-Associated Macrophages interaction with blood endothelial cells is associated to poor prognosis in diffuse large B cell lymphoma

Great work from
#JulietteFerrant #MikaelRoussel

#CyTOF and #scRNAseq of #TAM in #DLBCL
👇

https://www.biorxiv.org/content/10.1101/2022.12.08.519637v1

#dlbcl #tam #scrnaseq #CyTOF #mikaelroussel #julietteferrant

Last updated 2 years ago

Original post

Dr Victor Noriega Concepcion · @DrVictorNoriega

3 followers · 17 posts · Server mathstodon.xyz

Open media

Excellent presentation by @pebarba@twitter.com #ash22 @sehh_es@twitter.com #CART #DLBCL @GETH_info@twitter.com @Hemato_Vhebron@twitter.com YTB323 (Rapcabtagene Autoleucel) Demonstrates Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Phase I Study Update

#dlbcl #cart #ash22

Last updated 2 years ago

Original post